Science

Research results from five studies across three solid tumor types demonstrate the impact of Caris’ approach to molecular profiling across the continuum of cancer care IRVING, Texas, Feb. 13, 2023 /PRNewswire/ — Caris Life Sciences®(Caris),

TORONTO, March 1, 2022 /PRNewswire/ – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and